195 related articles for article (PubMed ID: 19811659)
1. Chromophobe renal cell cancer--review of the literature and potential methods of treating metastatic disease.
Stec R; Grala B; Maczewski M; Bodnar L; Szczylik C
J Exp Clin Cancer Res; 2009 Oct; 28(1):134. PubMed ID: 19811659
[TBL] [Abstract][Full Text] [Related]
2. DOG1, cyclin D1, CK7, CD117 and vimentin are useful immunohistochemical markers in distinguishing chromophobe renal cell carcinoma from clear cell renal cell carcinoma and renal oncocytoma.
Zhao W; Tian B; Wu C; Peng Y; Wang H; Gu WL; Gao FH
Pathol Res Pract; 2015 Apr; 211(4):303-7. PubMed ID: 25596994
[TBL] [Abstract][Full Text] [Related]
3. KIT expression in chromophobe renal cell carcinoma: comparative immunohistochemical analysis of KIT expression in different renal cell neoplasms.
Petit A; Castillo M; Santos M; Mellado B; Alcover JB; Mallofré C
Am J Surg Pathol; 2004 May; 28(5):676-8. PubMed ID: 15105658
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical study of c-KIT (CD117) expression in renal cell carcinoma.
Ahmed EA; Youssif ME
J Egypt Natl Canc Inst; 2009 Jun; 21(2):121-32. PubMed ID: 21057563
[TBL] [Abstract][Full Text] [Related]
5. Progesterone receptor reactivity in renal oncocytoma and chromophobe renal cell carcinoma.
Mai KT; Teo I; Belanger EC; Robertson SJ; Marginean EC; Islam S
Histopathology; 2008 Feb; 52(3):277-82. PubMed ID: 18081814
[TBL] [Abstract][Full Text] [Related]
6. HNF-1β as an immunohistochemical marker for distinguishing chromophobe renal cell carcinoma and hybrid oncocytic tumors from renal oncocytoma.
An J; Park CK; Kim M; Joo JW; Cho NH
Virchows Arch; 2021 Mar; 478(3):459-470. PubMed ID: 32816058
[TBL] [Abstract][Full Text] [Related]
7. Useful markers for differential diagnosis of oncocytoma, chromophobe renal cell carcinoma and conventional renal cell carcinoma.
Geramizadeh B; Ravanshad M; Rahsaz M
Indian J Pathol Microbiol; 2008; 51(2):167-71. PubMed ID: 18603673
[TBL] [Abstract][Full Text] [Related]
8. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
[TBL] [Abstract][Full Text] [Related]
9. [Immunohistochemical profile of renal cell tumours].
Gutiérrez Olivares VM; González Torres LM; Hunter Cuartas G; Niebles De la Hoz MC
Rev Esp Patol; 2019; 52(4):214-221. PubMed ID: 31530404
[TBL] [Abstract][Full Text] [Related]
10. Combined Immunohistochemistry for the "Three 7" Markers (CK7, CD117, and Claudin-7) Is Useful in the Diagnosis of Chromophobe Renal Cell Carcinoma and for the Exclusion of Mimics: Diagnostic Experience from a Single Institution.
Zhou J; Yang X; Zhou L; Zhang P; Wang C
Dis Markers; 2019; 2019():4708154. PubMed ID: 31737127
[TBL] [Abstract][Full Text] [Related]
11. Morphological, immunohistochemical, and chromosomal analysis of multicystic chromophobe renal cell carcinoma, an architecturally unusual challenging variant.
Foix MP; Dunatov A; Martinek P; Mundó EC; Suster S; Sperga M; Lopez JI; Ulamec M; Bulimbasic S; Montiel DP; Alaghehbandan R; Peckova K; Pivovarcikova K; Ondrej D; Rotterova P; Skenderi F; Prochazkova K; Dusek M; Hora M; Michal M; Hes O
Virchows Arch; 2016 Dec; 469(6):669-678. PubMed ID: 27631338
[TBL] [Abstract][Full Text] [Related]
12. Systemic therapy for chromophobe renal cell carcinoma: A systematic review.
Papanikolaou D; Ioannidou P; Koukourikis P; Moysidis K; Meditskou S; Koutsoumparis D; Hatzimouratidis K; Hatzivassiliou E
Urol Oncol; 2020 Apr; 38(4):137-149. PubMed ID: 31953002
[TBL] [Abstract][Full Text] [Related]
13. Distribution of subtypes of metastatic renal-cell carcinoma: correlating findings of fine-needle aspiration biopsy and surgical pathology.
Mai KT; Alhalouly T; Lamba M; Yazdi HM; Stinson WA
Diagn Cytopathol; 2003 Feb; 28(2):66-70. PubMed ID: 12561022
[TBL] [Abstract][Full Text] [Related]
14. Differential immunohistochemical and molecular profiling of conventional and aggressive components of chromophobe renal cell carcinoma: pitfalls for diagnosis.
Chen CV; Croom NA; Simko JP; Stohr BA; Chan E
Hum Pathol; 2022 Jan; 119():85-93. PubMed ID: 34800526
[TBL] [Abstract][Full Text] [Related]
15. Gene expression and oxidative stress markers profile associated with toxic metals in patients with renal cell carcinoma.
Tarabay HH; Abol-Enein H; Awadalla A; Mortada WI; Abdel-Aziz AF
Mol Biol Rep; 2022 Feb; 49(2):1161-1169. PubMed ID: 34851477
[TBL] [Abstract][Full Text] [Related]
16. Identification and Validation of Radiographic Enhancement for Reliable Differentiation of CD117(+) Benign Renal Oncocytoma and Chromophobe Renal Cell Carcinoma.
Amin J; Xu B; Badkhshan S; Creighton TT; Abbotoy D; Murekeyisoni C; Attwood KM; Schwaab T; Hendler C; Petroziello M; Roche CL; Kauffman EC
Clin Cancer Res; 2018 Aug; 24(16):3898-3907. PubMed ID: 29752278
[No Abstract] [Full Text] [Related]
17. The utility of epithelial membrane antigen and vimentin in the diagnosis of chromophobe renal cell carcinoma.
Khoury JD; Abrahams NA; Levin HS; MacLennan GT
Ann Diagn Pathol; 2002 Jun; 6(3):154-8. PubMed ID: 12089725
[TBL] [Abstract][Full Text] [Related]
18. Distinct immunophenotypes and prognostic factors in renal cell carcinoma with sarcomatoid differentiation: a systematic study of 19 immunohistochemical markers in 42 cases.
Yu W; Wang Y; Jiang Y; Zhang W; Li Y
BMC Cancer; 2017 Apr; 17(1):293. PubMed ID: 28449664
[TBL] [Abstract][Full Text] [Related]
19. Sporadic oncocytic tumors with features intermediate between oncocytoma and chromophobe renal cell carcinoma: comprehensive clinicopathological and genomic profiling.
Liu YJ; Ussakli C; Antic T; Liu Y; Wu Y; True L; Tretiakova MS
Hum Pathol; 2020 Oct; 104():18-29. PubMed ID: 32673684
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical diagnosis of renal neoplasms.
Truong LD; Shen SS
Arch Pathol Lab Med; 2011 Jan; 135(1):92-109. PubMed ID: 21204715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
